Deflazacort for the treatment of Duchenne Dystrophy: A systematic review

BACKGROUND: To complete a systematic review and meta-analysis based on the clinical question: Is Deflazacort (DFZ), a prednisolone derivative, an effective therapy for improving strength, with acceptable side effects, in children with Duchenne Dystrophy (DD)? METHODS: MEDLINE, EMBASE, Current Conten...

Descripción completa

Detalles Bibliográficos
Autores principales: Campbell, Craig, Jacob, Pierre
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2003
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC222985/
https://www.ncbi.nlm.nih.gov/pubmed/12962544
http://dx.doi.org/10.1186/1471-2377-3-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC222985/
https://www.ncbi.nlm.nih.gov/pubmed/12962544
http://dx.doi.org/10.1186/1471-2377-3-7

Ejemplares similares